Managing separation: How divestment and splits create different complications

There have been many conversations about mergers and acquisitions in pharma – why they’re happening, their impact, how they’re being managed, potential fall out, and transition strategies. Less has been said, however, about those companies moving in the opposite direction through divestment, spin offs, or splits. Last year, Baxter announced it would be splitting into […]